Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-05-12 Sale |
2020-05-13 6:30 pm |
CONSTELLATION PHARMACEUTICALS INC | CNST | Audia James E Director |
6,100 | $50.1 | $305,622 | 25,434 (Direct) |
View |
| 2020-05-12 Sale |
2020-05-13 6:30 pm |
CONSTELLATION PHARMACEUTICALS INC | CNST | Senderowicz Adrian Chief Medical Officer |
9,357 | $50.18 | $469,488 | 115,547 (Direct) |
View |
| 2020-05-11 Sale |
2020-05-13 6:29 pm |
CONSTELLATION PHARMACEUTICALS INC | CNST | GOLDSMITH MARK A Director 10% Owner |
4,325 | $50.05 | $216,474 | 194,933 (Indirect Direct) |
View |
| 2020-05-11 Sale |
2020-05-13 6:25 pm |
CONSTELLATION PHARMACEUTICALS INC | CNST | Raythatha Jigar See Remarks |
9,235 | $50.17 | $463,281 | 872,050 (Direct) |
View |
| 2020-05-08 Sale |
2020-05-12 9:41 pm |
CONSTELLATION PHARMACEUTICALS INC | CNST | Reeve Emma Chief Financial Officer |
28,803 | $49.53 | $1,426,678 | 279,613 (Direct) |
View |
| 2020-05-06 Sale |
2020-05-07 4:39 pm |
CONSTELLATION PHARMACEUTICALS INC | CNST | Trojer Patrick Chief Scientific Officer |
10,000 | $45.16 | $451,553 | 33,330 (Direct) |
View |
| 2020-05-05 Sale |
2020-05-07 4:34 pm |
CONSTELLATION PHARMACEUTICALS INC | CNST | Valentine Karen See Remarks |
17,310 | $40.08 | $693,714 | 230,808 (Direct) |
View |
| 2020-05-06 Sale |
2020-05-07 4:28 pm |
CONSTELLATION PHARMACEUTICALS INC | CNST | Audia James E Director |
7,500 | $45.15 | $338,600 | 31,534 (Direct) |
View |
| 2020-05-05 Sale |
2020-05-07 4:25 pm |
CONSTELLATION PHARMACEUTICALS INC | CNST | GOLDSMITH MARK A Director 10% Owner |
14,608 | $43.97 | $642,368 | 231,692 (Indirect Direct) |
View |
| 2020-04-27 Sale |
2020-04-29 8:20 pm |
CONSTELLATION PHARMACEUTICALS INC | CNST | GOLDSMITH MARK A Director 10% Owner |
400 | $40.12 | $16,049 | 169,913 (Indirect Direct) |
View |
| 2020-04-27 Sale |
2020-04-29 8:03 pm |
CONSTELLATION PHARMACEUTICALS INC | CNST | Valentine Karen See Remarks |
400 | $40.13 | $16,052 | 113,985 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-06-04 Option Award |
2020-06-08 6:15 pm |
N/A 2030-06-04 |
CONSTELLATION PHARMACEUTICALS INC | CNST | Audia James E Director |
13,171 | $0 | 13,171 (Direct) |
View |
| 2020-06-04 Option Award |
2020-06-08 6:14 pm |
N/A 2030-06-04 |
CONSTELLATION PHARMACEUTICALS INC | CNST | GOLDSMITH MARK A Director 10% Owner |
13,171 | $0 | 13,171 (Direct) |
View |
| 2020-06-04 Option Award |
2020-06-08 6:13 pm |
N/A 2030-06-04 |
CONSTELLATION PHARMACEUTICALS INC | CNST | Braunstein Scott Director |
13,171 | $0 | 13,171 (Direct) |
View |
| 2020-05-12 Exercise |
2020-05-13 6:30 pm |
N/A N/A |
CONSTELLATION PHARMACEUTICALS INC | CNST | Senderowicz Adrian Chief Medical Officer |
9,357 | $5.51 | 115,547 (Direct) |
View |
| 2020-05-12 Exercise |
2020-05-13 6:30 pm |
N/A 2027-07-10 |
CONSTELLATION PHARMACEUTICALS INC | CNST | Senderowicz Adrian Chief Medical Officer |
9,357 | $0 | 115,547 (Direct) |
View |
| 2020-05-12 Exercise |
2020-05-13 6:29 pm |
N/A N/A |
CONSTELLATION PHARMACEUTICALS INC | CNST | GOLDSMITH MARK A Director 10% Owner |
300 | $11.5 | 194,933 (Indirect) |
View |
| 2020-05-11 Exercise |
2020-05-13 6:29 pm |
N/A N/A |
CONSTELLATION PHARMACEUTICALS INC | CNST | GOLDSMITH MARK A Director 10% Owner |
2,725 | $1.55 | 194,933 (Indirect) |
View |
| 2020-05-12 Exercise |
2020-05-13 6:29 pm |
N/A N/A |
CONSTELLATION PHARMACEUTICALS INC | CNST | GOLDSMITH MARK A Director 10% Owner |
1,300 | $7.6 | 194,933 (Indirect) |
View |
| 2020-05-11 Exercise |
2020-05-13 6:29 pm |
N/A 2021-03-10 |
CONSTELLATION PHARMACEUTICALS INC | CNST | GOLDSMITH MARK A Director 10% Owner |
4,325 | $0 | 194,933 (Direct) |
View |
| 2020-05-11 Exercise |
2020-05-13 6:25 pm |
N/A N/A |
CONSTELLATION PHARMACEUTICALS INC | CNST | Raythatha Jigar See Remarks |
9,235 | $5.51 | 872,050 (Direct) |
View |
| 2020-05-11 Exercise |
2020-05-13 6:25 pm |
N/A 2027-07-10 |
CONSTELLATION PHARMACEUTICALS INC | CNST | Raythatha Jigar See Remarks |
9,235 | $0 | 872,050 (Direct) |
View |
| 2020-05-08 Exercise |
2020-05-12 9:41 pm |
N/A N/A |
CONSTELLATION PHARMACEUTICALS INC | CNST | Reeve Emma Chief Financial Officer |
9,284 | $11.5 | 279,613 (Direct) |
View |
| 2020-05-11 Exercise |
2020-05-12 9:41 pm |
N/A N/A |
CONSTELLATION PHARMACEUTICALS INC | CNST | Reeve Emma Chief Financial Officer |
1,178 | $7.6 | 279,613 (Direct) |
View |
| 2020-05-11 Exercise |
2020-05-12 9:41 pm |
N/A N/A |
CONSTELLATION PHARMACEUTICALS INC | CNST | Reeve Emma Chief Financial Officer |
10,736 | $8.76 | 279,613 (Direct) |
View |
| 2020-05-08 Exercise |
2020-05-12 9:41 pm |
N/A 2028-07-18 |
CONSTELLATION PHARMACEUTICALS INC | CNST | Reeve Emma Chief Financial Officer |
28,803 | $0 | 279,613 (Direct) |
View |
| 2020-05-11 Exercise |
2020-05-12 9:41 pm |
N/A N/A |
CONSTELLATION PHARMACEUTICALS INC | CNST | Reeve Emma Chief Financial Officer |
1,520 | $6.61 | 279,613 (Direct) |
View |
| 2020-05-08 Exercise |
2020-05-12 9:41 pm |
N/A N/A |
CONSTELLATION PHARMACEUTICALS INC | CNST | Reeve Emma Chief Financial Officer |
6,085 | $8.04 | 279,613 (Direct) |
View |
| 2020-05-06 Exercise |
2020-05-07 4:39 pm |
N/A N/A |
CONSTELLATION PHARMACEUTICALS INC | CNST | Trojer Patrick Chief Scientific Officer |
7,164 | $7.6 | 33,330 (Direct) |
View |
| 2020-05-06 Exercise |
2020-05-07 4:39 pm |
N/A N/A |
CONSTELLATION PHARMACEUTICALS INC | CNST | Trojer Patrick Chief Scientific Officer |
2,836 | $5.62 | 33,330 (Direct) |
View |
| 2020-05-06 Exercise |
2020-05-07 4:39 pm |
N/A 2028-03-05 |
CONSTELLATION PHARMACEUTICALS INC | CNST | Trojer Patrick Chief Scientific Officer |
10,000 | $0 | 33,330 (Direct) |
View |
| 2020-05-05 Exercise |
2020-05-07 4:34 pm |
N/A N/A |
CONSTELLATION PHARMACEUTICALS INC | CNST | Valentine Karen See Remarks |
14,843 | $11.5 | 230,808 (Direct) |
View |
| 2020-05-06 Exercise |
2020-05-07 4:34 pm |
N/A N/A |
CONSTELLATION PHARMACEUTICALS INC | CNST | Valentine Karen See Remarks |
2,467 | $8.76 | 230,808 (Direct) |
View |
| 2020-05-05 Exercise |
2020-05-07 4:34 pm |
N/A 2028-07-18 |
CONSTELLATION PHARMACEUTICALS INC | CNST | Valentine Karen See Remarks |
17,310 | $0 | 230,808 (Direct) |
View |
| 2020-05-05 Exercise |
2020-05-07 4:25 pm |
N/A N/A |
CONSTELLATION PHARMACEUTICALS INC | CNST | GOLDSMITH MARK A Director 10% Owner |
1,050 | $11.5 | 231,692 (Indirect) |
View |
| 2020-05-05 Exercise |
2020-05-07 4:25 pm |
N/A N/A |
CONSTELLATION PHARMACEUTICALS INC | CNST | GOLDSMITH MARK A Director 10% Owner |
9,138 | $1.55 | 231,692 (Indirect) |
View |
| 2020-05-05 Exercise |
2020-05-07 4:25 pm |
N/A N/A |
CONSTELLATION PHARMACEUTICALS INC | CNST | GOLDSMITH MARK A Director 10% Owner |
4,420 | $7.6 | 231,692 (Indirect) |
View |
| 2020-05-05 Exercise |
2020-05-07 4:25 pm |
N/A 2021-03-10 |
CONSTELLATION PHARMACEUTICALS INC | CNST | GOLDSMITH MARK A Director 10% Owner |
14,608 | $0 | 231,692 (Direct) |
View |
| 2020-04-27 Exercise |
2020-04-29 8:20 pm |
N/A N/A |
CONSTELLATION PHARMACEUTICALS INC | CNST | GOLDSMITH MARK A Director 10% Owner |
400 | $1.55 | 169,913 (Indirect) |
View |
| 2020-04-27 Exercise |
2020-04-29 8:20 pm |
N/A 2021-03-10 |
CONSTELLATION PHARMACEUTICALS INC | CNST | GOLDSMITH MARK A Director 10% Owner |
400 | $0 | 169,913 (Direct) |
View |
| 2020-04-27 Exercise |
2020-04-29 8:03 pm |
N/A N/A |
CONSTELLATION PHARMACEUTICALS INC | CNST | Valentine Karen See Remarks |
400 | $11.5 | 113,985 (Direct) |
View |
| 2020-04-27 Exercise |
2020-04-29 8:03 pm |
N/A 2028-07-18 |
CONSTELLATION PHARMACEUTICALS INC | CNST | Valentine Karen See Remarks |
400 | $0 | 113,985 (Direct) |
View |